Literature DB >> 1972752

Biochemical and radiohistochemical analyses of alpha-2 adrenergic receptors in the kindling model of epilepsy.

L S Chen1, J B Weingart, J O McNamara.   

Abstract

Biochemical and radiohistochemical methods were used to study alterations in alpha-2 adrenergic receptors in the kindling model of epilepsy. The radioligands used for antagonist and agonist binding were [3H]idazoxan and [3H]p-aminoclonidine, respectively. Radioligand binding to membranes isolated from eight brain regions disclosed a small (14%) but statistically significant reduction in [3H]idazoxan binding in a single area, amygdala-pyriform-entorhinal cortex. This was confirmed by a larger (25%) reduction (P less than .02) in agonist binding in the same region. These reductions were present in animals sacrificed 1 day, but not 2 weeks, after the last kindled seizure. Quantitative radiohistochemical studies identified a bilaterally symmetric reduction of approximately 20% of [3H]p-aminoclonidine binding in the pyriform cortex and the central, medial and lateral amygdaloid nuclei. No significant differences were detected in nine other structures. We propose that the reduction in alpha-2 receptor binding contributes in part to the reduced sensitivity of pyriform cortex neurons of kindled animals to the inhibitory effects of alpha 2 agonists. The reduced alpha-2-receptor binding may also underlie a transient attenuation of alpha-2 receptor-mediated neuro-transmission and thereby constitute one mechanism contributing to kindling development.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1972752

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  2 in total

1.  The α2B-adrenergic receptor is mutant in cortical myoclonus and epilepsy.

Authors:  Maurizio De Fusco; Riccardo Vago; Pasquale Striano; Carlo Di Bonaventura; Federico Zara; Davide Mei; Min Seuk Kim; Shmuel Muallem; Yunjia Chen; Qin Wang; Renzo Guerrini; Giorgio Casari
Journal:  Ann Neurol       Date:  2014-01-02       Impact factor: 10.422

2.  A point mutation (D79N) of the alpha2A adrenergic receptor abolishes the antiepileptogenic action of endogenous norepinephrine.

Authors:  S Janumpalli; L S Butler; L B MacMillan; L E Limbird; J O McNamara
Journal:  J Neurosci       Date:  1998-03-15       Impact factor: 6.167

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.